Health Care & Life Sciences » Biotechnology | AEterna Zentaris Inc.

AEterna Zentaris Inc.

AEterna Zentaris Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
EUR0.8
Market Cap
EUR41.86 M
Shares Outstanding
16.21 M
Public Float
-
AEterna Zentaris Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.92
Market Cap
$47.68 M
Shares Outstanding
16.21 M
Public Float
9.88 M

Profile

Address
315 Sigma Drive
Charleston South Carolina 29486
United States
Employees -
Website http://www.aezsinc.com
Updated 07/08/2019
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.

Financials

View All
Created with Highcharts 5.0.14AEterna Zentaris Inc.Net Income. Fiscal year is January-December. All values CAD Thousands.28 06728 06718 98218 98264 26064 26033 06833 06821 80121 8015 4275 427201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14AEterna Zentaris Inc.Sales/Revenue. Fiscal year is January-December. All values CAD Thousands.6 3626 36212126976971 2071 2071 1981 19834 84134 841201320142015201620172018010k20k30k40k

Robin Smith Hoke
Director
Jonathan M. Pollack
Director